DaVita Agrees To Pay $383.5 Million in A Wrongful Death Case
DaVita Agrees To Pay $383.5 Million in A Wrongful Death Case
Introduction
One of the largest dialysis providers, DaVita Inc., recently agreed to pay $383.5 million to the families of three patients who died of cardiac arrest following dialysis treatment at DaVita's. The Denver-based company was ordered to compensate for the wrongful death by a Denver jury in June 2018. The compensation included $125 million in punitive and $1.5 million to $5 million in compensatory damages.
DaVita was blamed in the lawsuit filed by the families for not forewarning about the health risks of GranuFlo treatment which caused toxic pH imbalances and alkalosis in the patients. Attorneys representing the plaintiffs asserted that the dialysis provider was aware of the toxicity of the product. Granuflo lawsuits were centralized in the District of Massachusetts as a multidistrict litigation in 2013 (MDL No. 2428; In Re: Fresenius GranuFlo/NaturaLyte Dialysate Litigation) before Judge Douglas P. Woodlock.
Comments
Latest News
Attorneys Seek Reconsideration of Talc MDL Daubert Ruling
Categories: General
Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…
Philips resolves DreamStation suits for $1.1B
Categories: Settlements
Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…
FDA OKs Generic OTC Naloxone Spray Approved by FDA
Categories: FDA Related
The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.
…